BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25885115)

  • 1. Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.
    El Khachibi M; Diakite B; Hamzi K; Badou A; Senhaji MA; Bakhchane A; Jouhadi H; Barakat A; Benider A; Nadifi S
    BMC Cancer; 2015 Feb; 15():81. PubMed ID: 25885115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.
    Wiechec E; Wiuf C; Overgaard J; Hansen LL
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):397-407. PubMed ID: 21135262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.
    Riahi A; Kharrat M; Lariani I; Chaabouni-Bouhamed H
    Fam Cancer; 2014 Dec; 13(4):603-9. PubMed ID: 25069718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
    Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
    J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
    D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
    Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison Between Full-COLD PCR/HRM and PCR Sequencing for Detection of Mutations in Exon 9 of PIK3CA in Breast Cancer Patients.
    Ghalamkari S; Khosravian F; Mianesaz H; Kazemi M; Behjati M; Hakimian SM; Salehi M
    Appl Biochem Biotechnol; 2019 Mar; 187(3):975-983. PubMed ID: 30109561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers].
    Zhang HT; Lu YF; Zeng J; Lin J; Liao QH; Wan FQ
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):480-2. PubMed ID: 17686308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis.
    Vorkas PA; Christopoulos K; Kroupis C; Lianidou ES
    Clin Biochem; 2010 Jan; 43(1-2):178-85. PubMed ID: 19747471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific BRCA1 gene variations amongst young Moroccan breast cancer patients.
    Tazzite A; Nadiffi S; Kottwitz D; El Amrani M; Jouhadi H; Benider A; Moumen A; Sefrioui H
    Genet Mol Res; 2014 Jan; 13(1):791-8. PubMed ID: 24615043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S; Crapolicchio A; Lacalamita R; Bruno M; Monaco A; Petroni S; Schittulli F; Longo S; Digennaro M; Calistri D; Mangia A; Paradiso A
    Mutat Res; 2005 Oct; 578(1-2):395-405. PubMed ID: 16026807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
    Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
    Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
    Coulet F; Pires F; Rouleau E; Lefol C; Martin S; Colas C; Cohen-Haguenauer O; Giurgea I; Fajac A; Noguès C; Demange L; Hardouin A; Lidereau R; Soubrier F
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):677-90. PubMed ID: 20858050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
    de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
    Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing.
    Michils G; Hollants S; Dehaspe L; Van Houdt J; Bidet Y; Uhrhammer N; Bignon YJ; Vermeesch JR; Cuppens H; Matthijs G
    J Mol Diagn; 2012 Nov; 14(6):623-30. PubMed ID: 23034506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.
    Ward BD; Hendrickson BC; Judkins T; Deffenbaugh AM; Leclair B; Ward BE; Scholl T
    J Mol Diagn; 2005 Feb; 7(1):139-42. PubMed ID: 15681486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
    Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
    Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.